Description:

Z1041: Tumor Measurement Report (TMR) NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=214B3C72-1BE1-3F2B-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=214B3C72-1BE1-3F2B-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/21/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Z1041: Tumor Measurement Report (TMR) NCT00513292

No Instruction available.

  1. StudyEvent: Z1041: Tumor Measurement Report (TMR)
    1. No Instruction available.
Header Module
Visit
Header
Was a tumor assessment performed at this visit (for target lesions?)
Organ
cm
Header
TARGET LESIONS
Percent change
Percent change
Non-target Lesions
Was an assessment performed for non-target lesions at this visit?
Are there any nontarget lesions?
Organ
Method of Evaluation
Lesion status
Was the non-target lesion identified on the baseline evaluation
Has the patient been diagnosed with a distant metastatic progression that has not been previously reported
Follow-up Status Of Target Lesions
Target Lesion Response Status
Target Lesion Response Status
Non-Target Lesion Response Status
Non-Target Lesion Response Status
Overall Response
Overall Response Status at This Assessment
Footer

Similar models